Single-dose Palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containig steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL).